Weekly wKRd-D in newly diagnosed multiple myeloma achieves unprecedented results
Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA
13 Dec 2019
FLT3-inhibition in infants with acute lymphoblastic leukaemia
Dr Patrick Brown - Johns Hopkins University, Baltimore, USA
13 Dec 2019
Chronic lymphocytic leukaemia highlights from ASH 2019
Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia
13 Dec 2019
Benefits of apixaban among venous thromboembolism patients with active cancer
Dr Alexander Cohen - Guys and St Thomas, London, UK
13 Dec 2019
Inotuzumab ozogamicin and chemotherapy with or without blinatumomab in Philadelp...
Dr Nicholas Short - MD Anderson Cancer Center, Houston, USA
13 Dec 2019
Dasatinib vs imatinib for paediatric Ph ALL
Dr Ching-Hon Pui - St Jude's Children's Research Hospital, Memphis, USA
12 Dec 2019
Study of quadruple combination for induction resistant myeloma reveals novel imm...
Dr Yael Cohen - Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
12 Dec 2019
KRd vs KTd followed by carfilzomib maintenance in newly diagnosed MM
Prof Heinz Ludwig - Wilhelmeninen Cancer Research Institute, Vienna, Austria
12 Dec 2019
Updates on REGN1979 in R/R B-cell non-Hodgkins lymphoma
Dr Rajat Bannerji - Rutgers Cancer Institute of New Jersey, New Brunswick, USA
12 Dec 2019
Eligibility criteria in acute myeloid leukaemia clinical trials
Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA
12 Dec 2019
Moxetumomab pasudotox-tdfk in heavily retreated r/r hairy cell leukaemia
Dr Robert Kreitman - National Cancer Institute, Bethesda, USA
12 Dec 2019
Azacitidine plus nivolumab in older adults with AML or MDS
Prof Annette Hay - Queen's University, Ontario, Canada
12 Dec 2019
